AU2003240253A1 - Polymorphisms in the human gene for htr3b and their use in diagnostic and therapeutic applications - Google Patents

Polymorphisms in the human gene for htr3b and their use in diagnostic and therapeutic applications

Info

Publication number
AU2003240253A1
AU2003240253A1 AU2003240253A AU2003240253A AU2003240253A1 AU 2003240253 A1 AU2003240253 A1 AU 2003240253A1 AU 2003240253 A AU2003240253 A AU 2003240253A AU 2003240253 A AU2003240253 A AU 2003240253A AU 2003240253 A1 AU2003240253 A1 AU 2003240253A1
Authority
AU
Australia
Prior art keywords
htr3b
polymorphisms
diagnostic
therapeutic applications
human gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003240253A
Inventor
Heinz Jurgen Brockmoller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Epidauros Biotechnologie AG
Original Assignee
Epidauros Biotechnologie AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epidauros Biotechnologie AG filed Critical Epidauros Biotechnologie AG
Publication of AU2003240253A1 publication Critical patent/AU2003240253A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
AU2003240253A 2002-05-15 2003-05-15 Polymorphisms in the human gene for htr3b and their use in diagnostic and therapeutic applications Abandoned AU2003240253A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02010209.1 2002-05-15
EP02010209 2002-05-15
PCT/EP2003/005120 WO2003097873A2 (en) 2002-05-15 2003-05-15 Polymorphisms in the human gene for htr3b and their use in diagnostic and therapeutic applications

Publications (1)

Publication Number Publication Date
AU2003240253A1 true AU2003240253A1 (en) 2003-12-02

Family

ID=29433071

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003240253A Abandoned AU2003240253A1 (en) 2002-05-15 2003-05-15 Polymorphisms in the human gene for htr3b and their use in diagnostic and therapeutic applications

Country Status (2)

Country Link
AU (1) AU2003240253A1 (en)
WO (1) WO2003097873A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006021348A1 (en) * 2004-08-26 2006-03-02 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine receptor 3b (5-ht3b)
US8697361B2 (en) 2008-02-28 2014-04-15 University Of Virginia Patent Foundation Serotonin transporter gene and treatment of alcoholism
CA2804174A1 (en) 2010-07-02 2012-01-05 University Of Virginia Patent Foundation Molecular genetic approach to treatment and diagnosis of alcohol and drug dependence
EA027743B1 (en) 2011-09-09 2017-08-31 Юниверсити Оф Вирджиния Пэтент Фаундейшн Molecular genetic approach to treatment and diagnosis of alcohol and drug dependence

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6462188B1 (en) * 1998-04-16 2002-10-08 The Institute For Genomic Research Human 5-HT3 receptor
US20010053849A1 (en) * 1999-06-16 2001-12-20 Mary Jeanne Kreek Plural biological sample arrays, and preparation and uses thereof

Also Published As

Publication number Publication date
WO2003097873A2 (en) 2003-11-27
WO2003097873A3 (en) 2004-03-11

Similar Documents

Publication Publication Date Title
AU2003243551A1 (en) Use of an anti-endotoxin drug in the prevention and treatment of disease
AU2003261073A1 (en) Combined diagnostic and therapeutic ultrasound system
AU2003299909A1 (en) Electro-stimulation and medical delivery device
AU2001293553A1 (en) Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment
AU2002952993A0 (en) Therapeutic and diagnostic agents
AU2003226537A1 (en) Modulators of the notch signalling pathway and uses thereof in medical treatment
AU2003286285A1 (en) Use of fgf-18 in the diagnosis and treatment of memory disorders
AU2002258728A1 (en) Gene brcc-3 and diagnostic and therapeutic uses thereof
AU2002303261A1 (en) Gene brcc2 and diagnostic and therapeutic uses thereof
AU2002305151A1 (en) Gene scc-112 and diagnostic and therapeutic uses thereof
HUP0201997A3 (en) Polymorphisms in the human mdr-1 gene and their use in diagnostic and therapeutic applications
AU2003208908A1 (en) Dye-bioconjugates for simultaneous optical diagnostic and therapeutic applications
AU2003238242A1 (en) Use of an anti-endotoxin drug in the prevention and treatment of disease
AU2002352566A1 (en) Use of corrinoids in the treatment of skin diseases
AU2003245858A1 (en) Uses of ngal-binding substances in the diagnosis and treatment of cancer diseases
AU2003240253A1 (en) Polymorphisms in the human gene for htr3b and their use in diagnostic and therapeutic applications
AU2003244498A1 (en) Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications
AU2003244455A1 (en) Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases
AU2003264094A1 (en) Polymorphisms in the human genes for oct1 and their use in diagnostic and therapeutic applications
AU2003271016A1 (en) Use of n-acetyl-d-aminoglycosamine in preparation of drugs for the treatment of cacer and metastasis
AU2003209459A1 (en) Protein-protein interactions in human tumours involving bcmp-7 and bcmp-11
AU2003280867A1 (en) Specific haplotypes of the mdr1 gene and their use in diagnosis and therapy
AU2003234140A1 (en) Aziridine compounds and their use in medical devices
AU2002355470A1 (en) Polymorphisms in the human gene for cyp1a2 and their use in diagnostic and therapeutic applications
AU2002247655A1 (en) Polymorphisms in the human gene for the multidrug resistance-associated protein 1 (mrp-1) and their use in diagnostic and therapeutic applications

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase